In part 2 of this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the educational benefit from using CGM for type 2 diabetes.
Richard Bergenstal MD, is an endocrinologist and Executive Director of the International Diabetes Center at Park Nicollet Methodist Hospital in Minneapolis, Minnesota.
Transcript of this video segment:Â CGM for Type 2 Diabetes
Freed: You know, the CGM, itâ€™s really made an impact, especially for type 1s. That is no doubt. The studies have been done. The results are in.
Freed: Cost is not even a question anymore. You know, it makes a huge difference in a personâ€™s quality of life. Letâ€™s look at type 2s for a second. I foresee type 2s using CGMs whether theyâ€™re on insulin or not if the insurance companies ever decided to pay for it. Because Iâ€™m a firm believer that if a person eats a piece of cherry pie and they look at their blood sugars theyâ€™re â€” itâ€™s only common sense that youâ€™re going to say, â€śI canâ€™t eat cherry pie anymore.â€ť
Bergenstal: I canâ€™t eat it as often anyway.
Freed: (Laughs) What are your thoughts of using it for an educational purpose for type 2s?
Bergenstal: Well, I think CGMs is rapidly making its way into the type 2 space right now. So, I mentioned that our diabetes center is sort of integrated into a multispecialty clinic. And so, we work closely with primary care and I must tell you, itâ€™s taken a while but theyâ€™re now starting to say, â€śWhy arenâ€™t we looking at blood sugars?â€ť Theyâ€™ve really been in a mindset of A1C as king and they based all their â€” now theyâ€™re saying, â€śYeah, I think youâ€™re right. Looking at these glucoses is interesting.â€ť And when we show them a CGM profile, they are amazed that they never had any idea what it was looking like. Now, you go, take it to a patient. And I agree with you. I think lifestyle modification is going to be a big deal in type 2 diabetes. And then, even medication selection. Moving a patient to start insulin or to start another drug and you can say, â€śHere is why. Look at your picture. And Iâ€™m selecting for you or hopefully with you the next medicine to try to smooth this out. Come back and weâ€™ll look at your profile again in a few weeks and weâ€™ll see if weâ€™re achieving our goal.â€ť
Freed: I can foresee with CGM, with intelligence, that if you ate three Big Macs, it would actually tell you, you did a stupid thing.
Bergenstal: Yeah. Â
Freed: And itâ€™ll prevent you from doing things in the future thatâ€™s â€”
Bergenstal: Oh, I think, yeah. The machine learning people, the guide to decision-making people are going to get into the act for sure and say, â€śWait, you tried that before. It didnâ€™t work so well,â€ť or, â€śHereâ€™s what happened.â€ť So, yeah, weâ€™re going to get â€” this is going to get smarter and smarter. Now, people still have to interact and agree and participate, but at least they can do it from a sense of having actual real data to look at.